These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 17661402

  • 1. A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury.
    Ma X, Hua J, Mohamood AR, Hamad AR, Ravi R, Li Z.
    Hepatology; 2007 Nov; 46(5):1519-29. PubMed ID: 17661402
    [Abstract] [Full Text] [Related]

  • 2. Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.
    Li Z, Soloski MJ, Diehl AM.
    Hepatology; 2005 Oct; 42(4):880-5. PubMed ID: 16175608
    [Abstract] [Full Text] [Related]

  • 3. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
    Santodomingo-Garzon T, Han J, Le T, Yang Y, Swain MG.
    Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218
    [Abstract] [Full Text] [Related]

  • 4. Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity.
    Wang B, Sun J, Li X, Zhou Q, Bai J, Shi Y, Le G.
    Nutr Res; 2013 Nov; 33(11):971-81. PubMed ID: 24176237
    [Abstract] [Full Text] [Related]

  • 5. CD4(+)Foxp3(+) Tregs protect against innate immune cell-mediated fulminant hepatitis in mice.
    Hou X, Song J, Su J, Huang D, Gao W, Yan J, Shen J.
    Mol Immunol; 2015 Feb; 63(2):420-7. PubMed ID: 25315497
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH, Kukes GD, Lambrecht N, Kashyap ML, Kamanna VS.
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb 15; 306(4):G320-7. PubMed ID: 24356885
    [Abstract] [Full Text] [Related]

  • 7. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ, Yeh MM, Van Rooyen DM, Teoh NC, Brooling J, Hou JY, Williams J, Clyne M, Nolan CJ, Farrell GC.
    J Gastroenterol Hepatol; 2009 Oct 15; 24(10):1658-68. PubMed ID: 19788606
    [Abstract] [Full Text] [Related]

  • 8. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
    Dinh TN, Kyaw TS, Kanellakis P, To K, Tipping P, Toh BH, Bobik A, Agrotis A.
    Circulation; 2012 Sep 04; 126(10):1256-66. PubMed ID: 22851544
    [Abstract] [Full Text] [Related]

  • 9. CD4+CD25+ regulatory T cells attenuate lipopolysaccharide-induced systemic inflammatory responses and promotes survival in murine Escherichia coli infection.
    Okeke EB, Okwor I, Mou Z, Jia P, Uzonna JE.
    Shock; 2013 Jul 04; 40(1):65-73. PubMed ID: 23635849
    [Abstract] [Full Text] [Related]

  • 10. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J, Fan H, Hao J, Ren Y, Chen L, Li G, Xie R, Yang Y, Qian K, Liu M.
    Transfusion; 2012 Jun 04; 52(6):1333-47. PubMed ID: 22098312
    [Abstract] [Full Text] [Related]

  • 11. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.
    Eur J Gastroenterol Hepatol; 2008 Sep 04; 20(9):843-54. PubMed ID: 18794597
    [Abstract] [Full Text] [Related]

  • 12. Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.
    Imajo K, Fujita K, Yoneda M, Nozaki Y, Ogawa Y, Shinohara Y, Kato S, Mawatari H, Shibata W, Kitani H, Ikejima K, Kirikoshi H, Nakajima N, Saito S, Maeyama S, Watanabe S, Wada K, Nakajima A.
    Cell Metab; 2012 Jul 03; 16(1):44-54. PubMed ID: 22768838
    [Abstract] [Full Text] [Related]

  • 13. Possible involvement and the mechanisms of excess trans-fatty acid consumption in severe NAFLD in mice.
    Obara N, Fukushima K, Ueno Y, Wakui Y, Kimura O, Tamai K, Kakazu E, Inoue J, Kondo Y, Ogawa N, Sato K, Tsuduki T, Ishida K, Shimosegawa T.
    J Hepatol; 2010 Aug 03; 53(2):326-34. PubMed ID: 20462650
    [Abstract] [Full Text] [Related]

  • 14. Suppression of alloimmunity in mice by regulatory T cells converted with conditioned media.
    Teng L, Liu L, Su Y, Yuan X, Li J, Fu Q, Chen S, Wang C.
    J Surg Res; 2011 Dec 03; 171(2):797-806. PubMed ID: 20538297
    [Abstract] [Full Text] [Related]

  • 15. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P, Barkin JS.
    Am J Gastroenterol; 2003 Sep 03; 98(9):2093-7. PubMed ID: 14499793
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY.
    J Pharmacol Exp Ther; 2010 Dec 03; 335(3):553-61. PubMed ID: 20843956
    [Abstract] [Full Text] [Related]

  • 17. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD, Mao YQ, Zhu LJ, Li J, Xie Y, Wang L, Zhang GB.
    Chin Med J (Engl); 2012 Jun 03; 125(11):2004-11. PubMed ID: 22884069
    [Abstract] [Full Text] [Related]

  • 18. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.
    Obesity (Silver Spring); 2010 Apr 03; 18(4):780-7. PubMed ID: 19798065
    [Abstract] [Full Text] [Related]

  • 19. Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice.
    Nan YM, Wu WJ, Fu N, Liang BL, Wang RQ, Li LX, Zhao SX, Zhao JM, Yu J.
    Scand J Gastroenterol; 2009 Apr 03; 44(9):1121-31. PubMed ID: 19606393
    [Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.
    J Gastroenterol Hepatol; 2012 Feb 03; 27(2):341-50. PubMed ID: 21929649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.